Professor Jennifer Hill is the Inaugural Bob Baxt AO Chair of Corporate and Commercial Law and Director of CLARS. Her scholarship on comparative corporate law and governance is widely cited in ...
Prof Langley was Deputy Editor of the Academy of Management Journal for qualitative research from 2022-2025, and co-editor of Strategic Organization from 2009 to 2022. She is also coeditor with ...
Located at Monash University’s Clayton campus, the Monash FutureLab is a globally-connected innovation hub that supports technological innovation and collaboration in material engineering, additive ...
Global delegates and DFAT visit Monash to learn about new frontiers in neuroscience research and technology; Global delegates and DFAT visit M ...
The NCHA’s Digital Library is Australia’s first secure digitised collection of real-world consultations between GPs and their adult patients, plus related data: including anonymised transcripts, ...
Managed in collaboration with co-Trustees the Honourable Justice Debra Mullins AO (Chair), Paul de Silva, and Peter Evans, the Viertel Foundation was established with an initial bequest of $60 million ...
Your study options Part-time study Part-time study Mature age learning Mature age learning ...
Monash University has again demonstrated its national research leadership and the excellence of its researchers, securing 78 new Australian Research Council (ARC) Discovery Projects worth $62.8 ...
Preclinical study found exposure to nanoplastics (tiny plastic particles) can rapidly progress Alzheimer’s disease and, subsequently, spread from the brain to other key organs such as the liver, heart ...
Seaport Therapeutics announces that the first patient has been dosed in a Phase 2b study (BUOY-1) of GlyphAlloTM (SPT-300 or Glyph Allopregnanolone) in major depressive disorder, with or without ...
“Our earlier studies showed IC7Fc could help manage type 2 diabetes, a metabolic disease. This new research shows it can also reduce atherosclerosis, meaning it slows the ‘clogging’ of the arteries, ...
Antimicrobial resistance (AMR) is one of the world’s most urgent health challenges, with the WHO’s new report showing there are ‘too few antibacterials in the pipeline’. Most of the ‘low-hanging fruit ...